Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.91B |
| 2 |
SPCX
SpaceX
SPCX
|
+$871M |
| 3 |
Eli Lilly
LLY
|
+$719M |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Netflix
NFLX
|
+$627M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.42B |
| 4 |
NVIDIA
NVDA
|
+$1.41B |
| 5 |
SNDK
Sandisk
SNDK
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.67% |
| 2 | Technology | 3.92% |
| 3 | Healthcare | 2.55% |
| 4 | Industrials | 2.24% |
| 5 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
13376
Nano X Imaging
NNOX
$54M
| $16.4K | ﹤0.01% |
+14,119
| New | +$26.6K |
|
13377
Emerson Radio
MSN
$10.4M
| $16.3K | ﹤0.01% |
+45,650
| New | +$18.8K |
|
|
MREO
13378
PUT
Mereo BioPharma
MREO
$45.5M
| $16.2K | ﹤0.01% |
51,000
-16,800
| -25% | -$5.04K |
|
|
KNDI
13379
CALL
Kandi Technologies Group
KNDI
$58.7M
| $16.1K | ﹤0.01% |
22,600
-18,400
| -45% | -$13.6K |
|
13380
Arcadia Biosciences
RKDA
$1.04M
| $16.1K | ﹤0.01% |
+23,738
| New | +$24.6K |
|
|
NCL
13381
DELISTED
Northann Corp
NCL
| $16K | ﹤0.01% |
+100,592
| New | +$16K |
|
|
OPENW
13382
Opendoor Technologies Inc Series K Warrants
OPENW
$4.63M
| $15.9K | ﹤0.01% |
32,100
+450
| +1% | +$270 |
|
13383
CALL
SkinHealth Systems
SKIN
$87.8M
| $15.8K | ﹤0.01% |
22,800
+300
| +1% | +$229 |
|
13384
ZW Data Action Technologies
CNET
$4.55M
| $15.8K | ﹤0.01% |
+12,703
| New | +$10.1K |
|
|
SCNI
13385
Scinai Immunotherapeutics
SCNI
$1.04M
| $15.7K | ﹤0.01% |
+6,226
| New | +$30.6K |
|
13386
Mercer International
MERC
$25.9M
| $15.6K | ﹤0.01% |
23,705
-141,634
| -86% | -$141K |
|
13387
5E Advanced Materials
FEAM
$52.3M
| $15.6K | ﹤0.01% |
+11,203
| New | +$18.7K |
|
13388
VistaGen Therapeutics
VTGN
$10.5M
| $15.6K | ﹤0.01% |
+68,839
| New | +$41.5K |
|
13389
PUT
Tenaya Therapeutics
TNYA
$150M
| $15.4K | ﹤0.01% |
+20,900
| New | +$15.9K |
|
13390
CALL
Ispire Technology
ISPR
$82.7M
| $15.3K | ﹤0.01% |
13,700
-1,100
| -7% | -$1.87K |
|
|
BON
13391
Bon Natural Life
BON
$8.94M
| $15K | ﹤0.01% |
+12,620
| New | +$16.1K |
|
|
OGI
13392
PUT
Organigram Holdings
OGI
$153M
| $14.9K | ﹤0.01% |
14,600
-4,300
| -23% | -$5.25K |
|
13393
Expion Energy, Inc. Common Stock
XPON
$4.73M
| $14.9K | ﹤0.01% |
+2,755
| New | +$19.6K |
|
|
ELOG
13394
Eastern International Ltd
ELOG
$7.6M
| $14.8K | ﹤0.01% |
17,481
-32,679
| -65% | -$30.3K |
|
13395
CALL
Kaltura
KLTR
$215M
| $14.8K | ﹤0.01% |
11,400
-11,300
| -50% | -$15.3K |
|
13396
Azitra
AZTR
$10.4M
| $14.5K | ﹤0.01% |
+86,242
| New | +$18.6K |
|
13397
VerifyMe
VRME
$8.59M
| $14.4K | ﹤0.01% |
+23,405
| New | +$17.2K |
|
|
NTCL
13398
NetClass Technology Inc
NTCL
$4.38M
| $14.2K | ﹤0.01% |
+2,024
| New | +$61.2K |
|
13399
CALL
Mind CTI
MNDO
$21M
| $14.1K | ﹤0.01% |
+13,700
| New | +$13.8K |
|
|
ALP
13400
Alpha Compute
ALP
$6.2M
| $14K | ﹤0.01% |
+1,104
| New | +$16.2K |
|
Similar funds
Citadel Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
- Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
- Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
- Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
- Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
- Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.